HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
RVMD
Revolution Medicines Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $44.53B
Market Cap
$44.53B
Enterprise Val
$41.78B
P/E Ratio
-25.18
P/B Ratio
17.09
Trailing PEG (1Y)
-0.19
As Of
Aug 20, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$2.61B
Return on Equity-96.44%
Return on Assets-63.25%
Current Ratio11.38
Debt/Equity0.46
LT Debt/Equity0.45
Revenue Per Share0.00

Income Statement

Jun 30, 2026
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$394.9M
SG&A$110.2M
Operating Expenses$505.1M
Operating Income-$505.1M
Interest Expense$23.8M
Tax Expense$0.00
Net Income-$644.4M
EPS (Basic)$-3.06
EPS (Diluted)$-3.06
EBIT-$620.6M
EBITDA-$616.1M
Consolidated Income-$644.4M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$820.3M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$4.03B
LT Investments$42.5M
Property, Plant & Equipment$162.5M
Intangibles$70.4M
Non-Current Assets$294.9M
Total Assets$4.32B
Accounts Payable$88.4M
Current Debt$16.8M
Current Liabilities$354.1M
LT Debt$1.17B
Non-Current Liabilities$1.36B
Total Liabilities$1.72B
Total Debt$1.19B
Retained Earnings-$3.97B
Shareholder Equity$2.61B
Shares Outstanding212,596,462

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow-$387.3M
Investing Cash Flow-$1.66B
Financing Cash Flow$2.42B
CapEx-$2.3M
Free Cash Flow-$389.6M
Depreciation & Amort.$4.5M
Stock-Based Comp$67.0M
Acquisitions / Disposals$0.00
Investment Activity-$1.66B
Debt Issued/Repaid$732.1M
Equity Issued/Repaid$1.69B
Dividends Paid$0.00
Net Change in Cash$374.5M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h